157 related articles for article (PubMed ID: 9787159)
1. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage.
Zhou P; Qian L; Bieszczad CK; Noelle R; Binder M; Levy NB; Craig RW
Blood; 1998 Nov; 92(9):3226-39. PubMed ID: 9787159
[TBL] [Abstract][Full Text] [Related]
2. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells.
Opferman JT; Iwasaki H; Ong CC; Suh H; Mizuno S; Akashi K; Korsmeyer SJ
Science; 2005 Feb; 307(5712):1101-4. PubMed ID: 15718471
[TBL] [Abstract][Full Text] [Related]
3. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
[TBL] [Abstract][Full Text] [Related]
4. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions.
Zhou P; Qian L; Kozopas KM; Craig RW
Blood; 1997 Jan; 89(2):630-43. PubMed ID: 9002967
[TBL] [Abstract][Full Text] [Related]
5. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages.
Dzhagalov I; St John A; He YW
Blood; 2007 Feb; 109(4):1620-6. PubMed ID: 17062731
[TBL] [Abstract][Full Text] [Related]
6. The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity.
Campbell CJ; Lee JB; Levadoux-Martin M; Wynder T; Xenocostas A; Leber B; Bhatia M
Blood; 2010 Sep; 116(9):1433-42. PubMed ID: 20525924
[TBL] [Abstract][Full Text] [Related]
7. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
Ogilvy S; Metcalf D; Print CG; Bath ML; Harris AW; Adams JM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14943-8. PubMed ID: 10611317
[TBL] [Abstract][Full Text] [Related]
8. EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway.
Ando T; Umezawa A; Suzuki A; Okita H; Sano M; Hiraoka Y; Aiso S; Saruta T; Hata J
Jpn J Cancer Res; 1998 Dec; 89(12):1326-33. PubMed ID: 10081494
[TBL] [Abstract][Full Text] [Related]
9. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
10. Long-term contribution to the myeloid compartment by lineage-committed stem cells.
Chen CC; Rivera A; Ron N; Sutkowski N; Dougherty JP; Ron Y
Blood; 1998 Nov; 92(9):3210-7. PubMed ID: 9787157
[TBL] [Abstract][Full Text] [Related]
11. Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival.
Strasser A; Elefanty AG; Harris AW; Cory S
EMBO J; 1996 Aug; 15(15):3823-34. PubMed ID: 8670887
[TBL] [Abstract][Full Text] [Related]
12. Myeloid cell factor-1 is a critical survival factor for multiple myeloma.
Zhang B; Gojo I; Fenton RG
Blood; 2002 Mar; 99(6):1885-93. PubMed ID: 11877256
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of hyperactivated AKT1 with additional genes activated in leukemia drives hematopoietic progenitor cells to cell cycle block and apoptosis.
Tang Y; Halvarsson C; Nordigården A; Kumar K; Åhsberg J; Rörby E; Wong WM; Jönsson JI
Exp Hematol; 2015 Jul; 43(7):554-64. PubMed ID: 25931014
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the antiapoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) and the stimulation of its message by gonadotropins in the rat ovary.
Leo CP; Hsu SY; Chun SY; Bae HW; Hsueh AJ
Endocrinology; 1999 Dec; 140(12):5469-77. PubMed ID: 10579309
[TBL] [Abstract][Full Text] [Related]
15. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
[TBL] [Abstract][Full Text] [Related]
16. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.
Aichberger KJ; Mayerhofer M; Krauth MT; Skvara H; Florian S; Sonneck K; Akgul C; Derdak S; Pickl WF; Wacheck V; Selzer E; Monia BP; Moriggl R; Valent P; Sillaber C
Blood; 2005 Apr; 105(8):3303-11. PubMed ID: 15626746
[TBL] [Abstract][Full Text] [Related]
17. Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis.
Innes KM; Szilvassy SJ; Davidson HE; Gibson L; Adams JM; Cory S
Exp Hematol; 1999 Jan; 27(1):75-87. PubMed ID: 9923446
[TBL] [Abstract][Full Text] [Related]
18. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.
Kikushige Y; Yoshimoto G; Miyamoto T; Iino T; Mori Y; Iwasaki H; Niiro H; Takenaka K; Nagafuji K; Harada M; Ishikawa F; Akashi K
J Immunol; 2008 Jun; 180(11):7358-67. PubMed ID: 18490735
[TBL] [Abstract][Full Text] [Related]
19. Transgenic bcl-2 is not sufficient to rescue all hematolymphoid defects in STAT5A/5B-deficient mice.
Snow JW; Abraham N; Ma MC; Bronson SK; Goldsmith MA
Exp Hematol; 2003 Dec; 31(12):1253-8. PubMed ID: 14662332
[TBL] [Abstract][Full Text] [Related]
20. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
